Connexion

Associations professionnelles et sites Web utiles

Lignes directrices de pratique clinique

Prise en charge active du troisième stade du travail : Prévention et prise en charge de l'hémorragie postpartum : No. 235 Octobre 2009 (Remplace no. 88, avril 2000). Int J Gynaecol Obstet. 2010; 108 (3): 258-267.

American Congress of Obstetricians and Gynecologists (ACOG). Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists, number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006; 108 (4): 1039-1047.

Institute for Healthcare Improvement (IHI). How-to Guide: Prevent obstetrical adverse events. Cambridge, MA: IHI; 2012.

Leduc D, Senikas V, Lalonde AB, Comité de pratique clinique obstétrique.  Prise en charge active du troisième stade du travail : Prévention et prise en charge de l'hémorragie postpartum. J Obstet Gynaecol Can. 2009; 31 (10): 980-993.

Lyndon A, Lagrew D, Shields L, Main E, Cape V. Improving health care response to obstetric hemorrhage, version 2.0: A California toolkit to transform maternity care. California Maternal Quality Care Collaborative. 2015.

Organisation mondiale de la santé (OMS). Recommandations de l'OMS pour la prévention et le traitement de l'hémorragie du post-partum, Genève : OMS; 2012.

Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top Guideline No. 52. Royal College of Obstetricians and Gynaecologists: 2011.

Autres ressources documentaires sur l'hémorragie obstétrique

Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014; 54 (7): 1756-1768. doi: 10.1111/trf.12550.

Amorim-Costa C, Mota R, Rebelo C, Silva PT.  Uterine compression sutures for postpartum hemorrhage: is routine postoperative cavity evaluation needed? Acta Obstet Gynecol Scand. 2011; 90 (7): 701-706. doi: 10.1111/j.1600-0412.2011.01137.x.

Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010; 117 (8): 929-936. doi: 10.1111/j.1471-0528.2010.02585.x.

Audureau E, Deneux-Tharaux C, Lefevre P, et al.  Practices for prevention, diagnosis and management of postpartum haemorrhage: impact of a regional multifaceted intervention.  BJOG. 2009; 116 (10): 1325-1333. doi: 10.1111/j.1471-0528.2009.02238.x.

Bohlmann MK, Rath W. Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines. Arch Gynecol Obstet. 2014; 289 (3): 555-567. doi: 10.1007/s00404-013-3016-4.

Chelmow, D. Postpartum haemorrhage: prevention. BMJ Clin Evid. 2011; Apr 4: pii 1410.

Chu CS, Brhlikova  P, Pollock AM. Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. J R Soc Med. 2012; 105 (8): 336-347. doi: 10.1258/jrsm.2012.120044.

Clark SL, Christmas JT, Frye DR, Meyers JA, Perlin JB. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol. 2014; 211 (1): 32.e1-9. doi: 10.1016/j.ajog.2014.03.031.

Conde-Agudelo A, Nieto A, Rosas-Bermudez A, Romero R. Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2013; 209 (1): 40.e1-.e17. doi: 10.1016/j.ajog.2013.03.015.

Du Y, Ye M, Zheng F. Active management of the third stage of labor with and without controlled cord traction: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2014; 93 (7): 626-633. doi: 10.1111/aogs.12424.

Einerson BD, Miller ES, Grobman WA. Does a postpartum hemorrhage patient safety program result in sustained changes in management and outcomes? Am J Obstet Gynecol. 2015; 212 (2): 140-4.e1. doi: 10.1016/j.ajog.2014.07.004.

Elati A, Weeks A. Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis. Obstet Gynecol. 2012; 120 (5): 1140-1148. doi: 10.1097/AOG.0b013e3182707341

Elgafor el Sharkwy IA. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study. Arch Gynecol Obstet. 2013; 288 (6): 1231-1236. doi: 10.1007/s00404-013-2896-7.

Fawcus S, Moodley J. Postpartum haemorrhage associated with caesarean section and caesarean hysterectomy.  Best Pract Res Clin Obstet Gynaecol. 2013; 27 (2): 233-249. doi: 10.1016/j.bpobgyn.2012.08.018.

Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PloS One. 2014; 9 (12): e113715.  doi: 10.1371/journal.pone.0113715.

Girard T, Mortl M, Schlembach D. New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm. Curr Opin Anaesthesiol. 2014; 27 (3): 267-274. doi: 10.1097/ACO.0000000000000081.

Gizzo S, Patrelli TS, Gangi SD, et al.  Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review.  Reprod Sci. 2013; 20 (9): 1011-1019. doi: 10.1177/1933719112468951.

Heesen M, Bohmer J, Klohr S, et al. Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis. Acta Anaesthesiol Scand. 2014; 58 (9): 1075-1085. doi: 10.1111/aas.12341.

Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin? J Obstet Gynaecol. 2011; 31 (8): 732-739. doi: 10.3109/01443615.2011.595982.

Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine massage for preventing postpartum haemorrhage.  Cochrane Database Syst Rev. 2013; 7: CD006431. doi: 10.1002/14651858.CD006431.pub3.

Hofmeyr GJ, Gulmezoglu AM, Novikova N, Lawrie TA. Postpartum misoprostol for preventing maternal mortality and morbidity.  Cochrane Database Syst Rev. 2013; 7: CD008982. doi: 10.1002/14651858.CD008982.pub2.

Hofmeyr GJ, Gulmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effectsBull World Health Organ. 2009; 87 (9): 666-677.

Hofmeyr GJ, Mshweshwe NT, Gulmezoglu AM. Controlled cord traction for the third stage of labour. Cochrane Database Syst Rev. 2015; 1: CD008020. doi: 10.1002/14651858.CD008020.pub2.

Fédération Internationale de Gynécologie et d'Obstétrique. Prevention of postpartum hemorrhage with misoprostol.  Int J Gynaecol Obstet. 2012; 119 (3): 213-214. doi: 10.1016/j.ijgo.2012.09.002.

Fédération Internationale de Gynécologie et d'Obstétrique. Treatment of postpartum hemorrhage with misoprostol.  Int J Gynaecol Obstet. 2012; 119 (3): 215-216. doi: 10.1016/j.ijgo.2012.09.003.

Fédération Internationale de Gynécologie et d'Obstétrique, International Confederation of Midwives. Déclaration de principe commune internationale. Initiative mondiale FIGO/ICM quant à la prévention de l'hémorragie post-partum. J Obstet Gynaecol Can. 2004; 26 (12): 1100-1102, 1108-1111.

James AH, McLintock C, Lockhart E. Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol. 2012; 87 (Suppl 1): S16-S22. doi: 10.1002/ajh.23156.

Jin B, Du Y, Zhang F, Zhang K, Wang L, Cui L. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2016; 29 (3): 400-407. doi: 10.3109/14767058.2014.1002394.

Kacmar RM, Mhyre JM, Scavone BM, Fuller AJ, Toledo P. The use of postpartum hemorrhage protocols in United States academic obstetric anesthesia units. Anesth Analg. 2014; 119 (4): 906-910. doi: 10.1213/ANE.0000000000000399.

Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative GroupBMC Pregnancy Childbirth. 2009; 9: 55. doi: 10.1186/1471-2393-9-55.

Lalonde A. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012; 117 (2): 108-118. doi: 10.1016/j.ijgo.2012.03.001.

Li Q, Yang ZQ, Mohammed W, Feng YL, Shi HB, Zhou X. Prophylactic uterine artery embolization assisted cesarean section for the prevention of intrapartum hemorrhage in high-risk patients. Cardiovasc Intervent Radiol. 2014; 37 (6): 1458-1463. doi: 10.1007/s00270-014-0855-8.

Mahmud G, Javaid K, Tasnim N, Tabassum A, Bangash KT. Where does ergometrine stand in prevention of postpartum haemorrhage in caesarean section? J Pak Med Assoc. 2014; 64 (8): 911-914.

Mori R, Nardin JM, Yamamoto N, Carroli G, Weeks, A.  Umbilical vein injection for the routine management of third stage of labour. Cochrane Database Syst Rev. 2012; 3: CD006176. doi: 10.1002/14651858.CD006176.pub2.

Nadisauskiene RJ, Kliucinskas M, Dobozinskas P, Kacerauskiene J. The impact of postpartum haemorrhage management guidelines implemented in clinical practice: a systematic review of the literature. Eur J Obstet Gynecol Reprod Biol. 2014; 178: 21-26. doi: 10.1016/j.ejogrb.2014.03.051.

Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010; (7): CD007872. doi: 10.1002/14651858.CD007872.pub2.

Oladapo OT, Fawole B, Blum J, Abalos E.  Advance misoprostol distribution for preventing and treating postpartum haemorrhage.  Cochrane Database Syst Rev. 2012; 2: CD009336. doi: 10.1002/14651858.CD009336.pub2.

Oladapo OT, Okusanya BO, Abalos E. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2012; 2: CD009332. doi: 10.1002/14651858.CD009332.pub2.

Olefile KM, Khondowe O, M'Rithaa D. Misoprostol for prevention and treatment of postpartum haemorrhage: A systematic review. Curationis. 2013; 36 (1): E1-E10. doi: 10.4102/curationis.v36i1.57.

Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol. 2010; 53 (1): 147-156. doi: 10.1097/GRF.0b013e3181cc406d.

Pinto A, Niola R, Brunese L, Pinto F, Losco M, Romano L. Postpartum hemorrhage: what every radiologist needs to know. Curr Probl Diagn Radiol. 2012; 41 (3): 102-110. doi: 10.1067/j.cpradiol.2011.07.007.

Porreco RP, Stettler RW. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol. 2010; 53 (1): 182-195. doi: 10.1097/GRF.0b013e3181cc4139.

Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health. 2013; 5: 737-752. doi: 10.2147/IJWH.S51661.

Rajan PV, Wing DA. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol. 2010; 53 (1): 165-181. doi: 10.1097/GRF.0b013e3181ce0965.

Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol. 2009; 147 (1): 15-20. doi: 10.1016/j.ejogrb.2009.06.018.

Roach MK, Abramovici A, Tita AT. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. Am J Perinatol. 2013; 30 (7): 523-528. doi: 10.1055/s-0032-1329184.

Rossi AC, Prefumo F. Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet. 2015; 291 (2): 273-280. doi: 10.1007/s00404-014-3444-9.

Sentilhes L, Lasocki S, Ducloy-Bouthors AS, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015; 114 (4): 576-587. doi: 10.1093/bja/aeu448.

Sheldon WR, Blum J, Durocher J, Winikoff B. Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opin Investig Drugs. 2012; 21 (2): 235-250. doi: 10.1517/13543784.2012.647405.

Sheldon WR, Blum J, Vogel JP, et al. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121 (Suppl 1): 5-13. doi: 10.1111/1471-0528.12636.

Sloan NL, Durocher J, Aldrich T, Blum J, Winikoff B.  What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG. 2010; 117 (7): 788-800. doi: 10.1111/j.1471-0528.2010.02567.x.

Su LL, Chong YS, Samuel M.  Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012; 2: CD005457. doi: 10.1002/14651858.CD005457.pub3.

Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet. 2013; 121 (2): 186-189. doi: 10.1016/j.ijgo.2012.12.009.

Tuncalp O, Hofmeyr GJ, Gulmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012; 8: CD000494. doi: 10.1002/14651858.CD000494.pub4.

Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R.  Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhageAust N Z J Obstet Gynaecol. 2008; 48 (1): 12-16. doi: 10.1111/j.1479-828X.2007.00823.x.

Westhoff G, Cotter AM, Tolosa JE.  Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.  Cochrane Database SystRev. 2013; 10: CD001808. doi: 10.1002/14651858.CD001808.pub2.

Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet. 2013; 287 (3): 463-468. doi: 10.1007/s00404-012-2593-y.